FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094624532> ?p ?o ?g. }

• W2094624532 endingPage "595" @default.
• W2094624532 startingPage "595" @default.
• W2094624532 abstract "Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection Victoria WY Wong, Carmen KM Chan, Dexter YL Leung, Timothy YY LaiDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Hong Kong, People&#39;s Republic of ChinaBackground: The purpose of this study was to assess the efficacy of oral valganciclovir in the treatment of anterior segment inflammation caused by cytomegalovirus (CMV) infection.Methods: Consecutive patients with anterior segment inflammation due to CMV causing anterior uveitis or corneal endotheliitis treated with oral valganciclovir were reviewed. Diagnosis of CMV infection was confirmed by polymerase chain reaction of the aqueous aspirate prior to commencement of oral valganciclovir. All patients were treated with an oral loading dose of 900 mg valganciclovir twice daily for at least 2 weeks, followed by an additional 450 mg valganciclovir twice-daily maintenance therapy. Changes in visual acuity, intraocular pressure (IOP), use of antiglaucomatous eye drops, and recurrence were analyzed.Results: Thirteen eyes of 11 patients were followed for a mean of 17.2 months. Two patients had bilateral corneal endotheliitis. All eyes had absence of anterior segment inflammation within 3 weeks after treatment. Following treatment, the mean logMAR visual acuity improved significantly from 0.58 at baseline to 0.37 at the last follow-up (P = 0.048). The mean IOP and number of antiglaucomatous eye drops also decreased significantly (P = 0.021 and P = 0.004, respectively). Five (38.5%) eyes had recurrence of anterior uveitis after valganciclovir was stopped and required retreatment with oral valganciclovir.Conclusion: Oral valganciclovir appeared to be effective in controlling CMV anterior uveitis, resulting in visual improvement and IOP reduction following control of inflammation. However, despite the initial clinical response in all cases, recurrence after cessation of oral valganciclovir could occur.Keywords: cytomegalovirus infection, inflammation, anterior uveitis, endotheliitis, ocular hypertension, antiviral, valganciclovir" @default.
• W2094624532 created "2016-06-24" @default.
• W2094624532 creator A5029106850 @default.
• W2094624532 creator A5051763034 @default.
• W2094624532 creator A5052589029 @default.
• W2094624532 creator A5072738713 @default.
• W2094624532 date "2012-04-01" @default.
• W2094624532 modified "2023-09-26" @default.
• W2094624532 title "Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection" @default.
• W2094624532 cites W1966545179 @default.
• W2094624532 cites W1987982022 @default.
• W2094624532 cites W2003595851 @default.
• W2094624532 cites W2007204668 @default.
• W2094624532 cites W2009087901 @default.
• W2094624532 cites W2011034024 @default.
• W2094624532 cites W2014230978 @default.
• W2094624532 cites W2017937639 @default.
• W2094624532 cites W2026630037 @default.
• W2094624532 cites W2031799413 @default.
• W2094624532 cites W2047663114 @default.
• W2094624532 cites W2055666380 @default.
• W2094624532 cites W2069923154 @default.
• W2094624532 cites W2096890979 @default.
• W2094624532 cites W2100642465 @default.
• W2094624532 cites W2105213849 @default.
• W2094624532 cites W2123502599 @default.
• W2094624532 cites W2126620160 @default.
• W2094624532 cites W2130887949 @default.
• W2094624532 cites W2151900696 @default.
• W2094624532 cites W2315363447 @default.
• W2094624532 cites W2313117567 @default.
• W2094624532 doi "https://doi.org/10.2147/opth.s30476" @default.
• W2094624532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3340120" @default.
• W2094624532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22553419" @default.
• W2094624532 hasPublicationYear "2012" @default.
• W2094624532 type Work @default.
• W2094624532 sameAs 2094624532 @default.
• W2094624532 citedByCount "8" @default.
• W2094624532 countsByYear W20946245322018 @default.
• W2094624532 countsByYear W20946245322019 @default.
• W2094624532 countsByYear W20946245322020 @default.
• W2094624532 countsByYear W20946245322021 @default.
• W2094624532 countsByYear W20946245322022 @default.
• W2094624532 countsByYear W20946245322023 @default.
• W2094624532 crossrefType "journal-article" @default.
• W2094624532 hasAuthorship W2094624532A5029106850 @default.
• W2094624532 hasAuthorship W2094624532A5051763034 @default.
• W2094624532 hasAuthorship W2094624532A5052589029 @default.
• W2094624532 hasAuthorship W2094624532A5072738713 @default.
• W2094624532 hasBestOaLocation W20946245321 @default.
• W2094624532 hasConcept C118487528 @default.
• W2094624532 hasConcept C141071460 @default.
• W2094624532 hasConcept C203014093 @default.
• W2094624532 hasConcept C2522874641 @default.
• W2094624532 hasConcept C2776194053 @default.
• W2094624532 hasConcept C2776317777 @default.
• W2094624532 hasConcept C2776409557 @default.
• W2094624532 hasConcept C2777732132 @default.
• W2094624532 hasConcept C2777965375 @default.
• W2094624532 hasConcept C2778257484 @default.
• W2094624532 hasConcept C2779820661 @default.
• W2094624532 hasConcept C2779984381 @default.
• W2094624532 hasConcept C2780727368 @default.
• W2094624532 hasConcept C2781092963 @default.
• W2094624532 hasConcept C2992250680 @default.
• W2094624532 hasConcept C71924100 @default.
• W2094624532 hasConceptScore W2094624532C118487528 @default.
• W2094624532 hasConceptScore W2094624532C141071460 @default.
• W2094624532 hasConceptScore W2094624532C203014093 @default.
• W2094624532 hasConceptScore W2094624532C2522874641 @default.
• W2094624532 hasConceptScore W2094624532C2776194053 @default.
• W2094624532 hasConceptScore W2094624532C2776317777 @default.
• W2094624532 hasConceptScore W2094624532C2776409557 @default.
• W2094624532 hasConceptScore W2094624532C2777732132 @default.
• W2094624532 hasConceptScore W2094624532C2777965375 @default.
• W2094624532 hasConceptScore W2094624532C2778257484 @default.
• W2094624532 hasConceptScore W2094624532C2779820661 @default.
• W2094624532 hasConceptScore W2094624532C2779984381 @default.
• W2094624532 hasConceptScore W2094624532C2780727368 @default.
• W2094624532 hasConceptScore W2094624532C2781092963 @default.
• W2094624532 hasConceptScore W2094624532C2992250680 @default.
• W2094624532 hasConceptScore W2094624532C71924100 @default.
• W2094624532 hasLocation W20946245321 @default.
• W2094624532 hasLocation W20946245322 @default.
• W2094624532 hasLocation W20946245323 @default.
• W2094624532 hasLocation W20946245324 @default.
• W2094624532 hasLocation W20946245325 @default.
• W2094624532 hasOpenAccess W2094624532 @default.
• W2094624532 hasPrimaryLocation W20946245321 @default.
• W2094624532 hasRelatedWork W2011034024 @default.
• W2094624532 hasRelatedWork W2026630037 @default.
• W2094624532 hasRelatedWork W2094624532 @default.
• W2094624532 hasRelatedWork W2136656825 @default.
• W2094624532 hasRelatedWork W2141305461 @default.
• W2094624532 hasRelatedWork W2893120306 @default.
• W2094624532 hasRelatedWork W4200325493 @default.
• W2094624532 hasRelatedWork W4285744376 @default.
• W2094624532 hasRelatedWork W4313825588 @default.

• next